305 related articles for article (PubMed ID: 18239678)
1. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration.
Gelisken F; Ziemssen F; Voelker M; Bartz-Schmidt KU; Inhoffen W
Eye (Lond); 2009 Mar; 23(3):694-702. PubMed ID: 18239678
[TBL] [Abstract][Full Text] [Related]
2. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
[TBL] [Abstract][Full Text] [Related]
3. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
[TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
[TBL] [Abstract][Full Text] [Related]
5. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease.
Wong LJ; Desai RU; Jain A; Feliciano D; Moshfeghi DM; Sanislo SR; Blumenkranz MS
Retina; 2008 Oct; 28(8):1151-8. PubMed ID: 18685542
[TBL] [Abstract][Full Text] [Related]
6. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.
Garg S; Brod R; Kim D; Lane RG; Maguire J; Fischer D
Clin Exp Ophthalmol; 2008 Apr; 36(3):252-6. PubMed ID: 18412594
[TBL] [Abstract][Full Text] [Related]
7. Retinal pigment epithelial tear after intravitreal bevacizumab injection.
Shah CP; Hsu J; Garg SJ; Fischer DH; Kaiser R
Am J Ophthalmol; 2006 Dec; 142(6):1070-2. PubMed ID: 17157598
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month results.
Cleary CA; Jungkim S; Ravikumar K; Kelliher C; Acheson RW; Hickey-Dwyer M
Eye (Lond); 2008 Jan; 22(1):82-6. PubMed ID: 17891059
[TBL] [Abstract][Full Text] [Related]
9. Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration.
Konstantinidis L; Ambresin A; Zografos L; Mantel I
Acta Ophthalmol; 2010 Nov; 88(7):736-41. PubMed ID: 19604160
[TBL] [Abstract][Full Text] [Related]
10. Retinal pigment epithelium tears after bevacizumab injection.
Yeh B; Ferrucci S
Optometry; 2011 Mar; 82(3):152-7. PubMed ID: 21130699
[TBL] [Abstract][Full Text] [Related]
11. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration.
Cunningham ET; Feiner L; Chung C; Tuomi L; Ehrlich JS
Ophthalmology; 2011 Dec; 118(12):2447-52. PubMed ID: 21872935
[TBL] [Abstract][Full Text] [Related]
12. Retinal pigment epithelial tears in ranibizumab-treated eyes.
Smith BT; Kraus CL; Apte RS
Retina; 2009 Mar; 29(3):335-9. PubMed ID: 19174716
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.
Nagiel A; Freund KB; Spaide RF; Munch IC; Larsen M; Sarraf D
Am J Ophthalmol; 2013 Nov; 156(5):981-988.e2. PubMed ID: 23972309
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
Avery RL; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ
Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
17. Retinal pigment epithelial tear after intravitreal ranibizumab.
Bakri SJ; Kitzmann AS
Am J Ophthalmol; 2007 Mar; 143(3):505-7. PubMed ID: 17317396
[TBL] [Abstract][Full Text] [Related]
18. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.
Spandau UH; Jonas JB
Am J Ophthalmol; 2006 Dec; 142(6):1068-70. PubMed ID: 17157597
[TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography predictors of retinal pigment epithelial tear following intravitreal bevacizumab injection.
Moroz I; Moisseiev J; Alhalel A
Ophthalmic Surg Lasers Imaging; 2009; 40(6):570-5. PubMed ID: 19928722
[TBL] [Abstract][Full Text] [Related]
20. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
